VMDNasdaqServices-Misc Health & Allied Services, NECFiscal year ends December 31
VIEMED HEALTHCARE, INC.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 3, 2026
$9.59+0.11 (+1.16%)
Close on Oct 19, 2026
- Market cap
- $394.40M
- P/E (TTM)
- 26.6
- Dividend yield
- –
VIEMED HEALTHCARE, INC. revenue by segment
By business segment
By product or service
| Revenue | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|
| Equipment and supply sales | $50.25M | $30.90M | $25.77M | $13.93M | $8.77M | $7.36M | $4.40M | $2.82M | 18.6% | +62.7% |
| Service revenues | $24.89M | $20.13M | $10.67M | $8.47M | $2.05M | $1.40M | $1.42M | $983.00K | 9.2% | +23.6% |
| COVID-19 response sales and services | – | $0 | $0 | $2.28M | $8.56M | $34.38M | $0 | – | – | – |
By region
From the segment and revenue-disaggregation notes of Viemed Healthcare's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.